Stem (NYSE:STEM) reported quarterly losses of $(0.27) per share which missed the analyst consensus estimate of $(0.21) by 28.57 percent. The company reported quarterly sales of $29.291 million which missed the analyst consensus estimate of $38.719 million by 24.35 percent. This is a 78.10 percent decrease over sales of $133.740 million the same period last year.